Literature DB >> 390760

Familial deficiency of a plasma factor stimulating vascular prostacyclin activity.

G Remuzzi, D Marchesi, R Misiani, G Mecca, G de Gaetano, M B Donati.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 390760     DOI: 10.1016/0049-3848(79)90098-7

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  6 in total

Review 1.  Pathogenesis of the hemolytic uremic syndromes: current concepts.

Authors:  B S Kaplan; V V Vedaranayanan
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

2.  Prostacyclin and thromboxane A.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-06

3.  Prostacyclin production following in vitro mixing of normal with hemolytic-uremic-syndrome serum.

Authors:  R L Siegler; J B Smith; M B Lynch; S F Mohammad
Journal:  West J Med       Date:  1988-07

4.  Post-transplantation outcome of patients with hemolytic-uremic syndrome: update.

Authors:  D Hébert; E M Kim; R K Sibley; M S Mauer
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

5.  Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease.

Authors:  A B Bridges; M McLaren; N A Scott; T H Pringle; G P McNeill; J J Belch
Journal:  Br Heart J       Date:  1993-02

6.  In vitro prostacyclin production in the hemolytic-uremic syndrome.

Authors:  R L Siegler; J B Smith; M B Lynch; S F Mohammad
Journal:  West J Med       Date:  1986-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.